Patents by Inventor Cho-Yau Yeung

Cho-Yau Yeung has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7674607
    Abstract: A novel transcription regulator of G+C-rich promoters, the murine G+C-rich Promoter Binding Protein (mGPBP), and its interaction pattern with other transcription factors are disclosed. A human homologue of mGPBP, hGPBP, is described as well.
    Type: Grant
    Filed: April 30, 2008
    Date of Patent: March 9, 2010
    Assignee: Munin Corporation
    Inventors: Cho-Yau Yeung, Li-Chung Hsu, Shu Liu
  • Patent number: 7521540
    Abstract: Polynucleotides encoding mammalian ECM signaling molecules affecting the cell adhesion, migration, and proliferation activities characterizing such complex biological processes as angiogenesis, chondrogenesis, and oncogenesis, are provided. The polynucleotide compositions include DNAs and RNAs comprising part, or all, of an ECM signaling molecule coding sequence, or biological equivalents. Polypeptide compositions are also provided. The polypeptide compositions comprise mammalian ECM signaling molecules, peptide fragments, inhibitory peptides capable of interacting with receptors for ECM signaling molecules, and antibody products recognizing Cyr61. Also provided are methods for producing mammalian ECM signaling molecules.
    Type: Grant
    Filed: January 31, 2001
    Date of Patent: April 21, 2009
    Assignee: Munin Corporation
    Inventors: Lester F. Lau, Cho-Yau Yeung, Jeffrey A. Greenspan
  • Publication number: 20090081228
    Abstract: Polynucleotides encoding mammalian ECM signaling molecules affecting the cell adhesion, migration, and proliferation activities characterizing such complex biological processes as angiogenesis, chondrogenesis, and oncogenesis, are provided. The polynucleotide compositions include DNAs and RNAs comprising part, or all, of an ECM signaling molecule coding sequence, or biological equivalents. Polypeptide compositions are also provided. The polypeptide compositions comprise mammalian ECM signaling molecules, peptide fragments, inhibitory peptides capable of interacting with receptors for ECM signaling molecules, and antibody products recognizing Cyr61. Also provided are methods for producing mammalian ECM signaling molecules.
    Type: Application
    Filed: August 19, 2008
    Publication date: March 26, 2009
    Applicant: MUNIN CORPORATION
    Inventors: Lester F. Lau, Cho-Yau Yeung, Jeffrey A. Greenspan
  • Publication number: 20090011500
    Abstract: A novel transcription regulator of G+C-rich promoters, the murine G+C-rich Promoter Binding Protein (mGPBP), and its interaction pattern with other transcription factors are disclosed. A human homologue of mGPBP, hGPBP, is described as well.
    Type: Application
    Filed: April 30, 2008
    Publication date: January 8, 2009
    Inventors: Cho-Yau Yeung, Li-Chung Hsu, Shu Liu
  • Patent number: 7368538
    Abstract: A novel transcription regulator of G+C-rich promoters, the murine G+C-rich Promoter Binding Protein (mGPBP), and its interaction pattern with other transcription factors are disclosed. A human homologue of mGPBP, hGPBP, is described as well.
    Type: Grant
    Filed: September 22, 2004
    Date of Patent: May 6, 2008
    Assignee: Munin Corporation
    Inventors: Cho-Yau Yeung, Li-Chung Hsu, Shu Liu
  • Publication number: 20050130227
    Abstract: A novel transcription regulator of G+C-rich promoters, the murine G+C-rich Promoter Binding Protein (mGPBP), and its interaction pattern with other transcription factors are disclosed. A human homologue of mGPBP, hGPBP, is described as well.
    Type: Application
    Filed: September 22, 2004
    Publication date: June 16, 2005
    Inventors: Cho-Yau Yeung, Li-Chung Hsu, Shu Liu
  • Publication number: 20040002124
    Abstract: Polynucleotides encoding mammalian ECM signaling molecules affecting the cell adhesion, migration, and proliferation activities characterizing such complex biological processes as angiogenesis, chondrogenesis, and oncogenesis, are provided. The polynucleotide compositions include DNAs and RNAs comprising part, or all, of an ECM signaling molecule coding sequence, or biological equivalents. Polypeptide compositions are also provided. The polypeptide compositions comprise mammalian ECM signaling molecules, peptide fragments, inhibitory peptides capable of interacting with receptors for ECM signaling molecules, and antibody products recognizing Cyr61. Also provided are methods for producing mammalian ECM signaling molecules.
    Type: Application
    Filed: October 16, 2002
    Publication date: January 1, 2004
    Inventors: Lester F Lau, Cho-Yau Yeung, Jeffrey A Greenspan
  • Patent number: 4822736
    Abstract: Disclosed are cultured mouse cells with amplified adenosine deaminase genes which greatly overproduce adenosine deaminase. The cells were isolated by growth in media containing alanosine, uridine, and a cytotoxic concentration of adenosine. Maximum enhancement of adenosine deaminase activity was achieved by also adding deoxycoformycin to the media and then serially increasing the deoxycoformycin concentration at 4 to 6 week intervals. Also disclosed is a cDNA homologous to mouse adenosine deaminase mRNA. The cDNA was produced by synthesis against RNA extracted from the cells containing amplified adenosine deaminase genes and then inserted into a bacterial plasmid. Multiple copies of the cDNA were produced by replication of the bacteria into which the plasmids were inserted.
    Type: Grant
    Filed: July 5, 1984
    Date of Patent: April 18, 1989
    Assignee: Baylor College of Medicine
    Inventors: Rodney E. Kellems, Cho-Yau Yeung